# Polyphenols as Antioxidants for Extending Food Shelf-Life and in the Prevention of Health Diseases: Encapsulation and Interfacial Phenomena

**Authors:** Marlene Costa, Zerrin Sezgin-Bayindir, Sonia Losada-Barreiro, Fátima Paiva-Martins, Luciano Saso, Carlos Bravo-Díaz

PMC · DOI: 10.3390/biomedicines9121909 · Biomedicines · 2021-12-14

## TL;DR

This review discusses how polyphenols, natural antioxidants, can help reduce oxidative stress and improve food shelf-life, especially when encapsulated for better delivery.

## Contribution

The paper highlights the role of encapsulation and interfacial phenomena in enhancing the effectiveness of polyphenols as antioxidants.

## Key findings

- Polyphenols can reduce oxidative stress and inhibit foodborne pathogens.
- Encapsulation improves the bioavailability and therapeutic effects of polyphenols.
- Nanoscale delivery systems are crucial for targeting intracellular oxidative damage.

## Abstract

Toxicity caused by the exposure to human-made chemicals and environmental conditions has become a major health concern because they may significantly increase the formation of reactive oxygen species (ROS), negatively affecting the endogenous antioxidant defense. Living systems have evolved complex antioxidant mechanisms to protect cells from oxidative conditions. Although oxidative stress contributes to various pathologies, the intake of molecules such as polyphenols, obtained from natural sources, may limit their effects because of their antioxidant and antimicrobial properties against lipid peroxidation and against a broad range of foodborne pathogens. Ingestion of polyphenol-rich foods, such as fruits and vegetables, help to reduce the harmful effects of ROS, but the use of supramolecular and nanomaterials as delivery systems has emerged as an efficient method to improve their pharmacological and therapeutic effects. Suitable exogenous polyphenolic antioxidants should be readily absorbed and delivered to sites where pathological oxidative damage may take place, for instance, intracellular locations. Many potential antioxidants have a poor bioavailability, but they can be encapsulated to improve their ideal solubility and permeability profile. Development of effective antioxidant strategies requires the creation of new nanoscale drug delivery systems to significantly reduce oxidative stress. In this review we provide an overview of the oxidative stress process, highlight some properties of ROS, and discuss the role of natural polyphenols as bioactives in controlling the overproduction of ROS and bacterial and fungal growth, paying special attention to their encapsulation in suitable delivery systems and to their location in colloidal systems where interfaces play a crucial role.

## Full-text entities

- **Genes:** PNLIP (pancreatic lipase) [NCBI Gene 5406] {aka PL, PNLIPD, PTL}, SOD1 (superoxide dismutase 1) [NCBI Gene 6647] {aka ALS, ALS1, HEL-S-44, IPOA, SOD, STAHP}, GBA3 (glucosylceramidase beta 3 (gene/pseudogene)) [NCBI Gene 57733] {aka CBG, CBGL1, GLUC, KLRP}, CYTB (cytochrome b) [NCBI Gene 4519] {aka MTCYB}, COMT (catechol-O-methyltransferase) [NCBI Gene 1312] {aka HEL-S-98n}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, CAT (catalase) [NCBI Gene 847], CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}, SLC5A1 (solute carrier family 5 member 1) [NCBI Gene 6523] {aka D22S675, NAGT, SGLT-1, SGLT1}, ABCC3 (ATP binding cassette subfamily C member 3) [NCBI Gene 8714] {aka ABC31, EST90757, MLP2, MOAT-D, MRP3, cMOAT2}, GSTK1 (glutathione S-transferase kappa 1) [NCBI Gene 373156] {aka GST, GST 13-13, GST13, GST13-13, GSTK1-1, hGSTK1}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Sis (sucrase isomaltase) [NCBI Gene 69983] {aka 2010204N08Rik, SI, Si-s}, DUOX2 (dual oxidase 2) [NCBI Gene 50506] {aka LNOX2, NOXEF2, P138-TOX, TDH6, THOX2}, LCT (lactase) [NCBI Gene 3938] {aka LAC, LPH, LPH1}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, SCLT1 (sodium channel and clathrin linker 1) [NCBI Gene 132320] {aka CAP-1A, CAP1A}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, ADIPOQ (adiponectin, C1Q and collagen domain containing) [NCBI Gene 9370] {aka ACDC, ACRP30, ADIPQTL1, ADPN, APM-1, APM1}, UGT1A (UDP glucuronosyltransferase family 1 member A complex locus) [NCBI Gene 7361] {aka GNT1, UGT, UGT1, UGT1A@}, IL16 (interleukin 16) [NCBI Gene 3603] {aka LCF, NIL16, PRIL16, prIL-16}, SLCO1A2 (solute carrier organic anion transporter family member 1A2) [NCBI Gene 6579] {aka OATP, OATP-A, OATP1A2, SLC21A3}, SELE (selectin E) [NCBI Gene 6401] {aka CD62E, ELAM, ELAM1, ESEL, LECAM2, selectin-e}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CYP4F3 (cytochrome P450 family 4 subfamily F member 3) [NCBI Gene 4051] {aka CPF3, CYP4F, CYPIVF3, LTB4H}, LEP (leptin) [NCBI Gene 3952] {aka LEPD, OB, OBS}, ABCB6 (ATP binding cassette subfamily B member 6 (LAN blood group)) [NCBI Gene 10058] {aka ABC, LAN, MTABC3, PRP, umat}, Akr1b8 (aldo-keto reductase family 1, member B8) [NCBI Gene 14187] {aka FR-1, Fgfrp, Fgrp}, ACSBG1 (acyl-CoA synthetase bubblegum family member 1) [NCBI Gene 23205] {aka BG, BG1, BGM, GR-LACS, LPD}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, GUSB (glucuronidase beta) [NCBI Gene 2990] {aka BG, MPS7}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}
- **Diseases:** cardiovascular, neurodegenerative (MESH:D019636), skin pigmentation disorders (MESH:D010859), inflammatory bowel diseases (MESH:D015212), hypoxia (MESH:D000860), obesity (MESH:D009765), chronic diseases (MESH:D002908), Crohn's disease (MESH:D003424), colon cancer (MESH:D015179), degeneration (MESH:D009410), skin aging (MESH:D012871), Hypertension (MESH:D006973), Cytotoxicity (MESH:D064420), CVD (MESH:D002318), ischemia (MESH:D007511), Health Diseases (OMIM:603663), hyperglycemia (MESH:D006943), allergies (MESH:D004342), prostate cancer (MESH:D011471), thrombotic (MESH:D013927), glioblastoma (MESH:D005909), cardiotoxicity (MESH:D066126), dyslipidemia (MESH:D050171), infectious disease (MESH:D003141), inflammatory (MESH:D007249), ulcerative colitis (MESH:D003093), atherosclerosis (MESH:D050197), diabetes type II (MESH:D003924), immune (MESH:D007154), common cold symptoms (MESH:D003139), diabetes (MESH:D003920), age-related and metabolic disorders (MESH:D008569), cancer (MESH:D009369), type I diabetes (MESH:D003922), necrosis (MESH:D009336), rheumatoid arthritis (MESH:D001172)
- **Species:** Glycine max (soybean, species) [taxon 3847], Pseudomonas aeruginosa (species) [taxon 287], Mus musculus (house mouse, species) [taxon 10090], Juglans regia (English walnut, species) [taxon 51240], PX clade (clade) [taxon 569578], Listeria monocytogenes (species) [taxon 1639], Helianthus annuus (common sunflower, species) [taxon 4232], Olea europaea (common olive, species) [taxon 4146], Escherichia coli (E. coli, species) [taxon 562], Danio rerio (leopard danio, species) [taxon 7955], Gallus gallus (bantam, species) [taxon 9031], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Sarcomyxa serotina (species) [taxon 40488]
- **Cell lines:** MCF-7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031), RPMI 2650 — Homo sapiens (Human), Head and neck squamous cell carcinoma, Cancer cell line (CVCL_1664), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC8698762/full.md

## Figures

21 figures with captions in the complete paper: https://tomesphere.com/paper/PMC8698762/full.md

## References

227 references — full list in the complete paper: https://tomesphere.com/paper/PMC8698762/full.md

---
Source: https://tomesphere.com/paper/PMC8698762